DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro.

Saved in:
Bibliographic Details
Title: DCMQA, a caffeoylquinic acid derivative alleviates NMDA-induced neurotoxicity via modulating GluN2A and GluN2B-containing NMDA receptors in vitro.
Authors: Yang, Yue1,2 (AUTHOR), Gao, Huan2 (AUTHOR), Liu, Wenwu1,2 (AUTHOR), Jiang, Xiaowen1,2 (AUTHOR), Shen, Zexu1,2 (AUTHOR), Li, Xiang1,2 (AUTHOR), Ren, Tianshu1,2 (AUTHOR), Xu, Zihua1,2 (AUTHOR), Cheng, Gang1 (AUTHOR), Zhao, Qingchun1,2 (AUTHOR) zhaoqingchun1967@163.com
Source: Toxicology in Vitro. Sep2020, Vol. 67, pN.PAG-N.PAG. 1p.
Database: Environment Complete
Description
ISSN:08872333
DOI:10.1016/j.tiv.2020.104888